Back

Trinity Biotech expands PrePsia patents to nine, seeks Nasdaq hearing after $15 million shortfall

Verifying
  • Trinity Biotech appointed Jordi Romero as Head of Commercial Operations – Europe.
  • Nine PrePsia patents are now granted across the United States and Europe.
  • Trinity plans to request a Nasdaq hearing after missing the $15 million MVPHS requirement.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.